
Philips to Acquire Spectranetics for $2.2 Billion
The deal will expand access to image-guided therapeutic devices that treat cardiac and peripheral vascular disease.
The deal will expand access to image-guided therapeutic devices that treat cardiac and peripheral vascular disease.